A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia - Döhner, Hartmut; Müller-Tidow, Carsten; Lübbert, Michael; Fiedler, Walter; Krämer, Alwin; Westermann, Jörg; Bug, Gesine; Schlenk, Richard Friedrich; Krug, Utz; Goeldner, Rainer-Georg; Hilbert, James; Taube, Tillmann; et al. (British journal of haematology, 2019)
Veröffentlicht: 19 November 2018